Benjamin Hohl
Finanzdirektor/CFO bei ENLIVEN THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Benjamin Hohl
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 13 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Benjamin Hohl
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Consultant / Advisor | |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CURIS, INC. | Biotechnology | Director of Finance/CFO | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Consultant / Advisor | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Royalty Pharma Cayman Partners LP
 Royalty Pharma Cayman Partners LP Pharmaceuticals: MajorHealth Technology Royalty Pharma Cayman Partners LP develops pharmaceutical products. The firm distributes products to hospitals, health care centers, medical outlet stores and other institutes. The company is located in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Brown University | College/University | Undergraduate Degree | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Private Equity Investor | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Founder General Counsel | |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
Putnam Associates LLC
 Putnam Associates LLC Miscellaneous Commercial ServicesCommercial Services Putnam Associates LLC engages in the provision of strategic consulting serving biopharmaceutical, diagnostics, and medical device clients. It specializes in corporate strategy, portfolio licensing and development strategy, new product, established products and franchise strategy, pricing, reimbursement and market access, and other related strategic projects. The company was founded by Kevin J. Gorman in 1988 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin | |
| Georgetown University School of Medicine | College/University | Doctorate Degree | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chairman | |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Hospital/Nursing Management | Corporate Officer/Principal | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Mavupharma, Inc.
 Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | Pharmaceuticals: Major | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Simcha Therapeutics Holding Co. LLC
 Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Simcha Therapeutics Holding Co. LLC is a biopharmaceutical company which engages in developing an engineered interleukin therapy. The company was founded in 2018 and is headquartered in New Haven, CT. | Biotechnology | Chairman | |
Phoenix Tissue Repair, Inc.
 Phoenix Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Phoenix Tissue Repair, Inc. develops biopharmaceuticals. The company is based in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Mediar Therapeutics, Inc.
 Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
Simcha Therapeutics, Inc.
 Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Simcha Therapeutics, Inc. operates as a biopharmaceutical company that develops engineered interleukin therapy products. The company was founded by Aaron Ring in 2018 and is headquartered in New Haven, CT. | Pharmaceuticals: Major | Chairman | |
Enliven Therapeutics, Inc. /US/
 Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Founder Founder Director/Board Member | |
SR One Capital Management LP
 SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Investment Managers | Private Equity Investor | |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| 501 ACQU | Financial Conglomerates | Chief Executive Officer General Counsel | |
| RAYZEBIO, INC. | Biotechnology | Chairman | |
| ARYA SCIENCES ACQUISITION CORP V | Financial Conglomerates | Director/Board Member | |
| Redmind LLC | Chief Executive Officer | ||
| Moores Cancer Center | Corporate Officer/Principal | ||
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Analyst | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| American Association For Cancer Research Foundation | Director/Board Member | ||
Ablexis LLC
 Ablexis LLC Packaged SoftwareTechnology Services Ablexis LLC develops next-generation platform for antibody drug discovery. It develops the AlivaMab Mouse, an innovative, next-generation transgenic mouse platform intended to enable the efficient discovery and development of the next generation of human therapeutic antibodies. The company was founded by Green L. Larry and Hiroaki Shizuya in December 2009 and is headquartered in Burlingame, CA. | Packaged Software | Chief Operating Officer |
Statistik
International
| Vereinigte Staaten | 50 |
| Kanada | 2 |
Sektoral
| Health Technology | 28 |
| Finance | 11 |
| Consumer Services | 6 |
| Commercial Services | 3 |
| Technology Services | 3 |
Operativ
| Director/Board Member | 110 |
| Corporate Officer/Principal | 34 |
| Independent Dir/Board Member | 32 |
| Founder | 17 |
| Chief Executive Officer | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Andrew Schwab | 45 |
| Richard Heyman | 33 |
| Rishi Gupta | 29 |
| Jake Bauer | 24 |
| Andrew Phillips | 23 |
| Rahul Ballal | 13 |
| Michael Gray | 12 |
| Galya Blachman | 9 |
| Helen Collins | 8 |
| Joseph Lyssikatos | 6 |
| Mika Derynck | 5 |
| Anish Patel | 4 |
| Samuel Kintz | 3 |
- Börse
- Insiders
- Benjamin Hohl
- Unternehmensverbindungen